Stains in primary biliary cholangitis: Untangling promise from bias
- 19 February 2026
- journal article
- editorial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 84 (2) , 337-339
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 7 references indexed in Scilit:
- Association between statin use and hepatic decompensation in patients with primary biliary cholangitis: A target trial emulation studyHepatology, 2026
- Review of methods to deal with the misalignment of times of eligibility, start of follow-up, and treatment assignment in studies explicitly aimed at emulating target trialsJournal of Clinical Epidemiology, 2025
- Obeticholic acid as second-line therapy for primary biliary cholangitis: Does target trial emulation solve the issue?Hepatology, 2024
- Avoidable flaws in observational analyses: an application to statins and cancerNature Medicine, 2019
- Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.American Journal of Epidemiology, 2016
- Negative ControlsEpidemiology, 2010
- Statin Adherence and Risk of AccidentsCirculation, 2009